Randomized controlled trial of olanedine and isodine for surgical site infection.
- Conditions
- Digestive surgery
- Registration Number
- JPRN-jRCT1051180002
- Lead Sponsor
- Iida Hiroya
- Brief Summary
The use of OG as a preoperative skin antiseptic would reduce the occurrence rate of deep incisional SSI.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 523
(1) Patients who will be hospitalized for digestive surgery during the period of this study
(2) Patients who will received upper gastrointestinal surgery (excluding gastric / intestinal fistula surgery), lower gastrointestinal surgery (excluding stoma (closure) operation), hepatobiliary pancreatic surgery (excluding laparoscopic cholecystectomy) under general anesthesia
(3) Patients who can obtain the consent of participating
(4) Patients regardless of sex
(5) Patients who can obtain written consent from themselves for participation
(1) Patients who had occurred allergies, hypersensitivity, and serious side effects to drugs used in this study
(2) Patients with severe thyroid dysfunction
(3) Patients of gastric or intestinal fistula construction in upper gastrointestinal surgery
(4) Patients of stoma construction or closure in lower gastrointestinal surgery
(5) Patients of laparoscopic cholecystectomy in hepatobiliary pancreatic surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Occurrence ratio of SSI
- Secondary Outcome Measures
Name Time Method Incidence of superficial SSI, deep SSI and organ/space SSI.<br>Examination of bacterial culture results of SSI cases.<br>Subgroup analysis by operation method<br>Incidence of adverse events